Boosting ATM activity alleviates ageing and extends lifespan in a mouse model of progeria.

Minxian Qian,Zuojun Liu,Linyuan Peng,Xiaolong Tang,Fanbiao Meng,Ying Ao,Mingyan Zhou,Ming Wang,Xinyue Cao,Baoming Qin,Zimei Wang,Zhongjun Zhou,Guangming Wang,Zhengliang Gao,Jun Xu,Baohua Liu
DOI: https://doi.org/10.7554/eLife.34836
IF: 7.7
2018-01-01
eLife
Abstract:DNA damage accumulates with age (Lombard et al., 2005). However, whether and how robust DNA repair machinery promotes longevity is elusive. Here, we demonstrate that ATM-centered DNA damage response (DDR) progressively declines with senescence and age, while low dose of chloroquine (CQ) activates ATM, promotes DNA damage clearance, rescues age-related metabolic shift, and prolongs replicative lifespan. Molecularly, ATM phosphorylates SIRT6 deacetylase and thus prevents MDM2-mediated ubiquitination and proteasomal degradation. Extra copies of Sirt6 extend lifespan in Atm-/- mice, with restored metabolic homeostasis. Moreover, the treatment with CQ remarkably extends lifespan of Caenorhabditis elegans, but not the ATM-1 mutants. In a progeria mouse model with low DNA repair capacity, long-term administration of CQ ameliorates premature aging features and extends lifespan. Thus, our data highlights a prolongevity role of ATM, for the first time establishing direct causal links between robust DNA repair machinery and longevity, and providing therapeutic strategy for progeria and age-related metabolic diseases.
What problem does this paper attempt to address?